Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	170.18	151.61	144.3	156.1	126.35
Short-Term Investments	114.84	72.24	114.71	21.86	12.52
Cash & Short-Term Investments	285.01	223.85	259.01	177.96	138.87
Cash Growth	27.33%	-13.58%	45.54%	28.15%	28.80%
Accounts Receivable	143.56	136.29	114.94	88.8	78.8
Other Receivables	17.17	1.75	0.53	0.17	0.13
Total Trade Receivables	160.73	138.04	115.47	88.98	78.93
Inventory	176.89	153.74	105.83	103.58	92.81
Other Current Assets	13.39	18.45	9.29	7.8	7.51
Total Current Assets	636.02	534.07	489.6	378.32	318.12
Net Property, Plant & Equipment	353.72	344.63	315.64	264.35	271.49
Goodwill	565.97	590.66	613.3	37.3	38.87
Long-Term Investments	-	11	15.21	2.41	3.99
Other Long-Term Assets	73.6	97.12	79.16	59.38	39.06
Total Assets	1,629	1,577	1,513	741.99	671.53
Accounts Payable	148.35	157.06	93.37	84.24	89.55
Accrued Expenses	-	-	126.09	-	-
Current Portion of Long-Term Debt	-	-	0.44	3.05	2.2
Current Portion of Leases	-	-	3.91	3	2.98
Other Current Liabilities	0.24	9.66	1.61	4.57	9.08
Total Current Liabilities	148.59	166.72	225.41	94.86	103.81
Long-Term Debt	-	-	589.58	72.84	74.78
Long-Term Leases	-	-	29.72	23.69	24.7
Other Long-Term Liabilities	-	-	28.78	21.93	22.72
Total Long-Term Liabilities	-	-	648.08	118.47	122.2
Total Liabilities	148.59	166.72	873.49	213.33	226.01
Common Stock	-	-	0.01	0.01	0.01
Treasury Stock	-	-	-247.43	-189.52	-150.48
Additional Paid-in Capital	-	-	486.06	455.08	422.42
Accumulated Other Comprehensive Income	-	-	-8.48	-8.62	-6.77
Retained Earnings	-	-	409.27	271.72	180.34
Total Common Shareholders' Equity	-	-	639.42	528.66	445.52
Shareholders' Equity	-	-	639.42	528.66	445.52
Total Liabilities & Equity	148.59	166.72	1,513	741.99	671.53
Total Debt	0	0	623.64	102.58	104.66
Net Cash (Debt)	285.01	223.85	-364.64	75.38	34.21
Net Cash Growth	27.33%	-	-	120.34%	-15.63%
Net Cash Per Share	5.91	4.30	-6.88	1.44	0.69
Book Value	0	0	639.42	528.66	445.52
Book Value Per Share	-	-	12.06	10.08	8.95
Tangible Book Value	-565.97	-590.66	26.13	491.36	406.65
Tangible Book Value Per Share	-11.74	-11.35	0.49	9.37	8.17

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q